Ionis Pharmaceuticals's total assets for Q3 2025 were $3.03B, an increase of 1.60% from the previous quarter. IONS total liabilities were $2.42B for the fiscal quarter, a 2.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.